​

Funding Round

Venture Round - Nucleix

Venture Round - Nucleix

Investment Firm

Overview

Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests.

Announced Date

Jan 05, 2022

Funding Type

Series Unknown

Highlights

Location

Asia

Social

Investor Lead

Sands Capital Ventures

Sands Capital Ventures

Sands Capital Ventures is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorRA Capital Management
Participant InvestorOrbiMed
Participant InvestorZohar Zisapel
Participant InvestorSands Capital Ventures

Round Details and Background

Nucleix raised $22000000 on 2022-01-05 in Venture Round

Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 30, 2018
Grant - Nucleix
1-2.9M
Apr 07, 2021
Venture Round - Nucleix
10-55.0M
Jan 05, 2022
Venture Round - Nucleix
4-22.0M
May 24, 2016
Seed Round - Nucleix
3-3.0M

Recent Activity

There is no recent news or activity for this profile.